France Fluoroscopy Systems Market Size, Share, By Product (Fluoroscopy Devices, C-Arms, Mini C-Arms, And Full Size C-Arms), By Mobility (Orthopaedic, Cardiovascular, Pain Management & Trauma, Neurology, Gastrointestinal, Urology, And Others), By End Use (Hospitals & Specialty Clinics, Diagnostic Imaging Centres, And Others), And France Fluoroscopy Systems Market Insights, Industry Trend, Forecasts to 2035.
Industry: HealthcareFrance Fluoroscopy Systems Market Insights Forecasts to 2035
- France Fluoroscopy Systems Market Size 2024: USD 70.3 Mn
- France Fluoroscopy Systems Market Size 2035: USD 104.8 Mn
- France Fluoroscopy Systems Market CAGR 2024: 3.7%
- France Fluoroscopy Systems Market Segments: Product, Mobility, and End Use

Get more details on this report -
The France fluoroscopy systems market refers to the sector of French medical imaging industry used in hospitals and diagnostic centers to support diagnostic, interventional and surgical procedures. Fluoroscopic systems can be fixed or mobile, as well as c-arms and digital fluoroscopy systems. Real-time X-ray imaging that assist many types of diagnostic and treatment processes including cardiovascular, orthopedic, gastroenterological, urological and pain management. The fluoroscopic systems market in France is supported by German government spending in healthcare, technological advancements, and regulatory frameworks that govern the industry, and clinical demands for less invasive and image guided interventional procedures.
The fluoroscopy systems in France are backed by government support, including the government investment nearly 7 billion in the Health Innovation Plan 2030 to enhance innovation in healthcare technologies, including advanced medical devices and diagnostic devices, as part of supporting international development and access to innovative medical technologies in France to enhance ability to develop innovative medical devices. Health-care spending accounted for approximately 11.5% of GDP in France in 2023 reflecting strong levels of investments by the public sector in health-care services, including fluoroscopy systems, which are essential components of healthcare.
As technology advances, France fluoroscopy systems providers are now using flat-panel detectors to observe digital fluoroscopy, resulted in a significant improvement in image quality while also lowering the amount of radiation needed for imaging, compared to traditional image intensifier equipment. Advances in AI-assisted imaging technology allow for improved performance of digital fluoroscopy through enhanced real-time processing accuracy and improved diagnostic capabilities. These advancements enable a further evolution of the hybrid imaging platform and provide options for optimising dose delivery and performing guided procedures. As a result, fluoroscopy systems have become more intelligent and effective as clinical tools.
Market Dynamics of the France Fluoroscopy Systems Market:
The France fluoroscopy systems market is driven by the increasing prevalence of chronic diseases requirement of frequent imaging, aging population creates an increase in the demand for diagnostic imaging services, expansion of diagnostic service infrastructures and modernization of hospitals, integration of digital health technologies and artificial Intelligence into imaging, promotes efficiency and acceptance of digital imaging solutions within clinical settings with strong government support for fluoroscopy systems market.
The France fluoroscopy systems market is restrained by the high cost of advanced imaging equipment and maintenance expenses, limit purchases especially for smaller clinics, strict regulatory and approval processes for new medical devices can slow market entry for next-generation fluoroscopy systems.
The future of France fluoroscopy systems market is bright and promising, with versatile opportunities emerging from the increased demand for minimal invasive procedures has created a need for real-time image guidance during these procedures, which has led to growth in portable and point-of-care fluoroscopic systems for use in emergency room, outpatient and rural health care practices, also government support for digital health innovation through initiatives such as Health Innovation 2030, partnerships between Public Sector Health Systems and Private Sector Technology Companies, which all provide further opportunities for expedited adoption and commercial expansion.
France Fluoroscopy Systems Market Report Coverage
| Report Coverage | Details |
|---|---|
| Base Year: | 2024 |
| Market Size in 2024: | USD 70.3 Million |
| Forecast Period: | 2024-2035 |
| Forecast Period CAGR 2024-2035 : | CAGR of 3.7% |
| 2035 Value Projection: | USD 104.8 Million |
| Historical Data for: | 2020-2023 |
| No. of Pages: | 210 |
| Tables, Charts & Figures: | 115 |
| Segments covered: | By Type, By Application |
| Companies covered:: | Hangzhou Richerpharm Technology Co., Ltd., Zhejiang Kangdi, Hisoar Pharmaceutical, Qilu Animal Health, Ningxia Tairui, Jiangsu Hualing, Inner Mongolia Veyong,Hubei Hongyuan, Others, and Key players |
| Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Market Segmentation
The France Fluoroscopy Systems Market share is classified into product, mobility, and end use.
By Product:
The France fluoroscopy systems market is divided by product into fluoroscopy devices, c-arms, mini c-arms, and full size c-arms. Among these, the fluoroscopy devices segment held the largest revenue market share in 2024 and is predicted to grow at a remarkable CAGR during the forecast period. Versatility and portability with reduction in patient transport, advanced imaging for procedures, meet clinical needs, and improve image quality all contribute to the fluoroscopy devices segment's largest share and higher spending on fluoroscopy systems when compared to other product.
By Mobility:
The France fluoroscopy systems market is divided by mobility into orthopaedic, cardiovascular, pain management & trauma, neurology, gastrointestinal, urology, and others. Among these, the cardiovascular segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The cardiovascular segment dominates because of high burden of cardiovascular diseases, essential for minimally invasive procedures, technological advancement improve workflow efficiency, and established healthcare infrastructure in France to handle complex cardiac cases.
By End Use:
The France fluoroscopy systems market is divided by end use into hospitals & specialty clinics, diagnostics imaging centres, and others. Among these, the hospitals & specialty clinics segment held the largest revenue market share in 2024 and is predicted to grow at a significant CAGR during the forecast period. High patient volume and complexity, availability of high-end equipment, wide range of procedures, and favourable reimbursement policies all contribute to the hospitals & specialty clinics segment's largest share and higher spending on fluoroscopy systems when compared to other end use.
Competitive Analysis:
The report offers the appropriate analysis of the key organisations/companies involved within the France fluoroscopy systems market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Key Companies in France Fluoroscopy Systems Market:
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- GE HealthCare
- Canon Medical Systems Corporation
- FUJIFILM Holdings Corporation
- Hologic Inc.
- Carestream Health Inc.
- Ziehm Imaging GmbH
- Shimadzu Corp.
- Esaote SpA
- Agfa-Gevaert NV
- DMS Group
- Orthoscan Inc.
- United Imaging Healthcare Co. Ltd.
- Mindray Medical International Limited
- Others
Recent Developments in France Fluoroscopy Systems Market:
In August 2025, Paris regional health in the United States introduced the GE P180 Fluoroscopy System from GE Healthcare, which offered high-resolution imaging and reduced radiation dose.
In July 2025, Siemens Healthineers obtained FDA clearance for two new multipurpose fluoroscopy systems, part of the Luminos Q. namix line, which includes models for both bedside and remote configurations, and were showcased during RSNA 2024.
In July 2023, Canon Medical Systems Corporation launched the Zexira i9 digital X-ray RF system, a multipurpose fluoroscopic table with new features designed to meet various clinical demands.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the France fluoroscopy systems market based on the below-mentioned segments:
France Fluoroscopy Systems Market, By Product
- Fluoroscopy Devices
- C-Arms
- Mini C-Arms
- Full Size C-Arms
France Fluoroscopy Systems Market, By Mobility
- Orthopaedic
- Cardiovascular
- Pain Management & Trauma
- Neurology
- Gastrointestinal
- Urology
- Others
France Fluoroscopy Systems Market, By End Use
- Hospitals & Specialty Clinics
- Diagnostic Imaging Centres
- Others
Frequently Asked Questions (FAQ)
-
Q: What is the France fluoroscopy systems market size?A: France fluoroscopy systems market is expected to grow from USD 70.3 million in 2024 to USD 104.8 million by 2035, growing at a CAGR of 3.7% during the forecast period 2025-2035.
-
Q: What are the key growth drivers of the market?A: Market growth is driven by the increasing prevalence of chronic diseases such as cardiovascular disorders and cancer that require frequent imaging, aging population, leading to greater diagnostic imaging usage, efforts to modernize hospital infrastructure and expand diagnostic services, integration of digital health technologies and AI in imaging workflows enhances efficiency and adoption in clinical settings.
-
Q: What factors restrain the France fluoroscopy systems market?A: Constraints include the high cost of advanced imaging equipment and maintenance expenses, limit purchases especially for smaller clinics, strict regulatory and approval processes for new medical devices can slow market entry for next-generation fluoroscopy systems.
-
Q: How is the market segmented by product?A: The market is segmented into fluoroscopy devices, c-arms, mini c-arms, and full size c-arms.
-
Q: Who are the key players in the France fluoroscopy systems market?A: Key companies include Koninklijke Philips N.V., Siemens Healthineers AG, GE HealthCare, Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Hologic Inc., Carestream Health Inc., Ziehm Imaging GmbH, Shimadzu Corp., Esaote SpA, Agfa-Gevaert NV, DMS Group, Orthoscan Inc., United Imaging Healthcare Co. Ltd., Mindray Medical International Limited, and Others.
-
Q: Who are the target audiences for this market report?A: The report targets market players, investors, end-users, government authorities, consulting and research firms, venture capitalists, and value-added resellers (VARs).
Need help to buy this report?